Helmy Siragy is an Endocrinology/Metabolic physician affiliated with University of Virginia Health System. OpenAlex indexes 233 publications with 9,857 citations (h-index 55).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingMedicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
58%Insulin Analog35.5%Lantus Solostar41%Novolog Flexpen18%Humalog Kwikpen U-10013%Levemir Flexpen9%Insulin Lispro Kwikpen U-1007%Lantus6%Basaglar Kwikpen U-1005%Part D<11 patientsBiguanide (metformin)7.2%Metformin Hcl62%Metformin Hcl Er38%Part D<11 patients+ 4 more classes in this area
Cardiovascular
28.6%Statin9%Atorvastatin Calcium69%Simvastatin31%Part D<11 patientsThiazide diuretic6.5%Hydrochlorothiazide100%Part D≥15 patients+ 3 more classes in this area
Hormonal (systemic)
13.4%l-Thyroxine11.2%Levothyroxine Sodium68%Synthroid32%Part D<11 patientsl-Triiodothyronine2.2%Liothyronine Sodium100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
8 NIH research awards on record, funded 1990–2020 per NIH RePORTER. The latest:
- (Pro)renin receptor regulates autophagy in diabetic kidney disease
University of Virginia
FY2020$405,000R01HL091535 - (Pro)renin receptor mediates obesity induced hypertension
University of Virginia
FY2020$363,375R01DK114875 - (Pro)renin receptor regulates autophagy in diabetic kidney disease
University of Virginia
FY2019$402,500R01HL091535
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- AT2 Receptor Activities and Pathophysiological Implications
Journal of Cardiovascular Pharmacology
2015 - Nephron-specific deletion of the prorenin receptor causes a urine concentration defect
American Journal of Physiology-Renal Physiology
2015 - Angiotensin Receptor Blockers: Pharmacology, Efficacy, and Safety
Journal of Clinical Hypertension
2011 - Role of the Intrarenal Renin-Angiotensin-Aldosterone System in Chronic Kidney Disease
American Journal of Nephrology
2010
Similar KOLs
Other experts from the same institution or the same specialty.
Frederick Hayden, MD
University of Virginia Health System
Allan Tsung, MD
University of Virginia Health System
Irving Kron, MD
University of Virginia Health System
Karen Ballen, MD
University of Virginia Health System
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”